West Pharmaceutical Services manufactures and sells packaging components and delivery systems for injectable drugs and healthcare products internationally. The Company's Proprietary Products segment offers stoppers and seals for injectable packaging systems and syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies. This segment serves biologic, generic, and pharmaceutical drug companies. Its Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves pharmaceutical, diagnostic, and medical device companies. West Pharmaceutical Services distributes products through its sales force and distribution network, as well as contract sales agents and regional distributors.
Show more
Type
Public
HQ
Exton, US
Founded
1923
Size (employees)
7,300 (est)
West Pharmaceutical Services was founded in 1923 and is headquartered in Exton, US
Report incorrect company information

West Pharmaceutical Services Office Locations

West Pharmaceutical Services has an office in Exton
Exton, US (HQ)
530 Herman O. W Dr
Show all (1)
Report incorrect company information

West Pharmaceutical Services Financials and Metrics

West Pharmaceutical Services Financials

West Pharmaceutical Services's revenue was reported to be $1.51 b in FY, 2016 which is a 7.8% increase from the previous period.
USD

Revenue (Q3, 2017)

398.2 m

Net income (Q3, 2017)

51 m

EBIT (Q3, 2017)

63.9 m

Market capitalization (20-Apr-2018)

6.9 b

Cash (30-Sep-2017)

269.3 m

EV

6.8 b
West Pharmaceutical Services's current market capitalization is $6.9 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

1.4 b1.4 b1.4 b1.5 b

Revenue growth, %

4%(2%)8%

General and administrative expense

239.8 m

R&D expense

36.8 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

341.8 m346.8 m368.9 m355.9 m335.9 m359.7 m344.5 m362.1 m388 m376.7 m387.7 m397.6 m398.2 m

General and administrative expense

56.1 m56.4 m57.5 m56 m55.2 m60.8 m54.6 m58.1 m62.5 m58.3 m61.6 m60.6 m61.5 m

R&D expense

9.6 m10 m9.9 m9.6 m7.5 m8.1 m8.5 m9.4 m8.8 m9 m10.3 m10 m9.1 m

Operating expense total

65.7 m66.4 m67.4 m65.6 m62.7 m68.9 m63.1 m67.5 m71.3 m67.3 m71.9 m70.6 m70.6 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

230 m255.3 m274.6 m203 m

Accounts Receivable

185.7 m179 m181.4 m200.5 m

Inventories

176.9 m181.5 m181.1 m199.3 m

Current Assets

650.7 m659.3 m673.7 m641.9 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

221.7 m230 m226.7 m246.8 m207.1 m252 m256.8 m178.1 m202.7 m205.9 m169.4 m226.6 m269.3 m

Accounts Receivable

198.2 m208.7 m209.6 m195.9 m189.5 m198.8 m194.6 m209.6 m219 m209.5 m224.8 m242.4 m251.8 m

Inventories

176.7 m187.5 m187.9 m185.7 m183.4 m187.2 m187.7 m194.1 m197.7 m201.1 m212.3 m211.3 m215.8 m

Current Assets

643.5 m686.6 m685.4 m679.5 m625.1 m679.9 m680.9 m630.7 m659.2 m658.1 m652.6 m717.8 m776.9 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

112.3 m127.1 m95.6 m143.6 m

Depreciation and Amortization

81 m84.8 m86.1 m88.1 m

Inventories

(14 m)(16 m)(11 m)(21.2 m)

Accounts Payable

4.6 m(3.5 m)17.2 m6.1 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

26.8 m27.1 m37.6 m31 m32.9 m60.7 m62.2 m22.1 m66.9 m104.5 m60.9 m99.7 m150.7 m

Inventories

187.2 m187.7 m194.1 m197.7 m201.1 m212.3 m

Accounts Payable

91.4 m93.6 m97.5 m107.3 m99 m106.1 m
USDY, 2017

EV/EBIT

106.8 x

Revenue/Employee

54.5 k

Financial Leverage

1.5 x
Show all financial metrics
Report incorrect company information

West Pharmaceutical Services News and Updates

Global Pharmaceutical Vial Market 2018 Key Players: Gerreshemier AG, Schott AG, West Pharmaceutical Services, Inc., Berk Company LLC, Piramal Glass Limited, Nipro Europe,.

WiseGuyReports.com adds “Pharmaceutical Vial Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2025”reports to its database. Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information